Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?-Reference-Cited by-同舟云学术

Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?

Published:2020-11-20 Issue:4-6 Volume:44 Page:519-523
ISSN:0191-3123
Container-title:Ultrastructural Pathology
language:en
Short-container-title:Ultrastructural Pathology

Author:

Obeidat Mohammad¹,Isaacson Alexandra L¹,Chen Stephanie J.¹,Ivanovic Marina¹,Holanda Danniele¹^ORCID

Affiliation:

1. Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Publisher

Informa UK Limited

Subject

Structural Biology,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01913123.2020.1850966

Reference14 articles.

1. Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease

2. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report

3. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

4. WHO. WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 2020. https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revaccination after Acute Kidney Injury Associated with Prior COVID-19 Vaccination: Case Report;Advances in Infectious Diseases;2024

2. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease;Molecular Genetics and Metabolism;2022-09

3. Therapeutics in rheumatology and the kidney;Rheumatology;2022-08-11

4. Safety profile of COVID-19 drugs in a real clinical setting;European Journal of Clinical Pharmacology;2022-01-28

5. Hydroxychloroquine administration exacerbates acute kidney injury complicated by lupus nephritis;Arthritis Research & Therapy;2022-01-03